Compare Kaynes Tech with Similar Stocks
Dashboard
With ROE of 8.1, it has a Very Expensive valuation with a 5.1 Price to Book Value
- The stock is trading at a discount compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of -28.98%, its profits have risen by 59.5% ; the PEG ratio of the company is 1.2
Underperformed the market in the last 1 year
Stock DNA
Industrial Manufacturing
INR 23,226 Cr (Mid Cap)
63.00
NA
0.00%
-0.04
8.09%
5.10
Total Returns (Price + Dividend) 
Kaynes Tech for the last several years.
Risk Adjusted Returns v/s 
Returns Beta
News

Kaynes Technology India Sees Sharp Open Interest Surge Amid Bearish Momentum
Kaynes Technology India Ltd has witnessed a significant 11.3% increase in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite this surge, the stock underperformed its sector and broader indices, raising questions about the directional bets underpinning this activity.
Read full news article
Kaynes Technology India Ltd Sees Sharp Open Interest Surge Amid Bearish Price Action
Kaynes Technology India Ltd has witnessed a notable 10.4% increase in open interest in its derivatives segment, signalling heightened market activity despite the stock’s recent underperformance. This surge in open interest, coupled with rising volumes and a weakening price trend, suggests a shift in market positioning that may indicate growing bearish bets among traders.
Read full news article
Kaynes Technology India Ltd Hits Intraday Low Amid Price Pressure
Shares of Kaynes Technology India Ltd declined sharply on 2 Feb 2026, touching an intraday low of ₹3,357.80, down 5.64% from the previous close. The stock underperformed its sector and broader market indices, reflecting immediate selling pressure and subdued market sentiment in the industrial manufacturing space.
Read full news article Announcements 
Announcement under Regulation 30 (LODR)-Credit Rating
31-Jan-2026 | Source : BSECredit Rating
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
28-Jan-2026 | Source : BSEEarnings call- Q3 2025-26
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
28-Jan-2026 | Source : BSEAnalyst/ Investor meet
Corporate Actions 
05 Feb 2026
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Dec 2025
Shareholding Compare (%holding) 
Promoters
None
Held by 30 Schemes (14.72%)
Held by 186 FIIs (8.88%)
Ramesh Kunhikannan (53.43%)
Nippon Life India Trustee Ltd-a/c Nippon India Small Cap Fund (3.63%)
16.91%
Quarterly Results Snapshot (Consolidated) - Sep'25 - QoQ
QoQ Growth in quarter ended Sep 2025 is 34.56% vs -31.59% in Jun 2025
QoQ Growth in quarter ended Sep 2025 is 62.73% vs -35.79% in Jun 2025
Half Yearly Results Snapshot (Consolidated) - Sep'25
Growth in half year ended Sep 2025 is 46.80% vs 63.53% in Sep 2024
Growth in half year ended Sep 2025 is 76.62% vs 94.86% in Sep 2024
Nine Monthly Results Snapshot (Consolidated) - Dec'24
YoY Growth in nine months ended Dec 2024 is 48.83% vs 53.28% in Dec 2023
YoY Growth in nine months ended Dec 2024 is 73.72% vs 89.45% in Dec 2023
Annual Results Snapshot (Consolidated) - Mar'25
YoY Growth in year ended Mar 2025 is 50.82% vs 60.25% in Mar 2024
YoY Growth in year ended Mar 2025 is 60.09% vs 92.53% in Mar 2024






